AMZN
Amazon.com, Inc.
AMZN has the edge over MBLY overall, supported by stronger valuation and stronger modeled upside.
MBLY
Mobileye Global Inc.
MBLY's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MBLY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Stable | |
| Strong |
MBLY's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
MBLY PE Valuation
MBLY has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MBLY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MBLY, with profitability improving. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MBLY on earnings quality, reporting a profit while its opponent remains loss making.
MBLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.41 | — |
| Q3 2026 | -$4.94 | -$4.52 |
| Q2 2026 | -$4.98 | -$1.33 |
| Q1 2026 | -$5.03 | -$1.35 |
| Q4 2025 | -$0.48 | +$3.34 |
| Q3 2025 | -$0.42 | +$3.22 |
| Q2 2025 | -$3.65 | -$3.38 |
| Q1 2025 | -$3.68 | -$3.48 |
| Q4 2024 | -$3.82 | -$3.79 |
MBLY lost $4.94 per share over the past year, a bigger loss than the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MBLY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MBLY on profitability, with a higher operating margin.
MBLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $492M | -2.4% |
| Q2 2026 | $508M | +0.4% |
| Q1 2026 | $558M | +27% |
| Q4 2025 | $446M | -9% |
| Q3 2025 | $504M | +3.7% |
| Q2 2025 | $506M | +15% |
| Q1 2025 | $438M | +83% |
| Q4 2024 | $490M | -23% |
MBLY's revenue fell from its 2023 peak and has held roughly level since: $492M last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -17% | +5 points |
| Q2 2026 | -5.9% | +8.7 points |
| Q1 2026 | -698% | -672 points |
| Q4 2025 | -31% | -14 points |
| Q3 2025 | -22% | +556 points |
| Q2 2025 | -15% | +6.8 points |
| Q1 2025 | -27% | +73 points |
| Q4 2024 | -18% | -29 points |
MBLY's operating margin was −17% last quarter, up 5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MBLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $72M | -50% |
| Q2 2026 | $114M | -43% |
| Q1 2026 | $45M | -53% |
| Q4 2025 | $86M | -55% |
| Q3 2025 | $143M | +38% |
| Q2 2025 | $199M | +3217% |
| Q1 2025 | $95M | +428% |
| Q4 2024 | $191M | +122% |
MBLY has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MBLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MBLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +6M shares |
| 1 year | +1.2% | +10M shares |
| 3 years | +1.7% | +14M shares |
| 5 years | +3.5% | +28.1M shares |
MBLY has 824M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9.5M |
| Q2 2026 | $23.5M |
| Q4 2025 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $2M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MBLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -202.0x | Net Cash |
| Q1 2023 | -12.5x | Net Cash |
| Q4 2022 | -3.7x | Net Cash |
| Q3 2022 | -2.5x | Net Cash |
| Q2 2022 | 5.8x | High |
| Q1 2022 | -2.3x | Net Cash |
| Q4 2021 | -2.3x | Net Cash |
MBLY has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MBLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.6 | Oversold |
| Stochastic | 13.5 | Oversold |
MBLY's weekly RSI is 29 (oversold) and its Stochastic is 14 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MBLY PE vs Consumer Cyclical Sector
MBLY has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MBLY on trend strength, trading above more of its moving averages.
MBLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.71 | 16% below |
| 20 week MA | $7.90 | 29% below |
| 50 week MA | $8.68 | 35% below |
| 100 week MA | $11.9 | 53% below |
| 200 week MA | $21.6 | 74% below |
MBLY is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MBLY on returns for 2026, with the stronger performance.
MBLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $27.0 | $34.0 | +26% |
| 2023 | $34.0 | $43.3 | +27% |
| 2024 | $43.3 | $20.0 | -54% |
| 2025 | $20.0 | $10.4 | -48% |
| 2026 YTD | $10.4 | $5.64 | -46% |
MBLY has finished lower in two of the last four years. It's down 46% so far in 2026.